nodes	percent_of_prediction	percent_of_DWPC	metapath
Amlexanox—FGF1—corneal epithelium—glaucoma	0.0941	0.345	CbGeAlD
Amlexanox—FGF1—cornea—glaucoma	0.0685	0.251	CbGeAlD
Amlexanox—IL3—connective tissue—glaucoma	0.0279	0.102	CbGeAlD
Amlexanox—FGF1—endothelium—glaucoma	0.0172	0.0631	CbGeAlD
Amlexanox—S100A13—eye—glaucoma	0.0137	0.0503	CbGeAlD
Amlexanox—S100A13—connective tissue—glaucoma	0.0132	0.0485	CbGeAlD
Amlexanox—S100A12—connective tissue—glaucoma	0.013	0.0478	CbGeAlD
Amlexanox—Throat sore—Dorzolamide—glaucoma	0.0114	0.0304	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Dorzolamide—glaucoma	0.0113	0.0302	CcSEcCtD
Amlexanox—Oropharyngeal pain—Dorzolamide—glaucoma	0.00902	0.0241	CcSEcCtD
Amlexanox—Oropharyngeal pain—Travoprost—glaucoma	0.00898	0.024	CcSEcCtD
Amlexanox—Oropharyngeal pain—Brinzolamide—glaucoma	0.00887	0.0237	CcSEcCtD
Amlexanox—Throat sore—Clonidine—glaucoma	0.00859	0.023	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Clonidine—glaucoma	0.00851	0.0228	CcSEcCtD
Amlexanox—FGF1—eye—glaucoma	0.00845	0.031	CbGeAlD
Amlexanox—FGF1—retina—glaucoma	0.00837	0.0307	CbGeAlD
Amlexanox—Pain—Dipivefrin—glaucoma	0.00837	0.0224	CcSEcCtD
Amlexanox—FGF1—connective tissue—glaucoma	0.00814	0.0298	CbGeAlD
Amlexanox—Throat sore—Betaxolol—glaucoma	0.00748	0.02	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Betaxolol—glaucoma	0.00741	0.0198	CcSEcCtD
Amlexanox—S100A13—Tizanidine—Brimonidine—glaucoma	0.00704	0.309	CbGdCrCtD
Amlexanox—Pain—Echothiophate—glaucoma	0.00701	0.0188	CcSEcCtD
Amlexanox—Nausea—Physostigmine—glaucoma	0.00684	0.0183	CcSEcCtD
Amlexanox—Oropharyngeal pain—Clonidine—glaucoma	0.00681	0.0182	CcSEcCtD
Amlexanox—Liver function test abnormal—Bimatoprost—glaucoma	0.0065	0.0174	CcSEcCtD
Amlexanox—S100A13—Tizanidine—Apraclonidine—glaucoma	0.00627	0.275	CbGdCrCtD
Amlexanox—Throat sore—Timolol—glaucoma	0.00611	0.0163	CcSEcCtD
Amlexanox—Oropharyngeal discomfort—Timolol—glaucoma	0.00606	0.0162	CcSEcCtD
Amlexanox—Oropharyngeal pain—Betaxolol—glaucoma	0.00593	0.0159	CcSEcCtD
Amlexanox—Liver function test abnormal—Brinzolamide—glaucoma	0.00541	0.0145	CcSEcCtD
Amlexanox—Liver function test abnormal—Pilocarpine—glaucoma	0.0052	0.0139	CcSEcCtD
Amlexanox—Mouth ulceration—Betaxolol—glaucoma	0.00487	0.013	CcSEcCtD
Amlexanox—Oropharyngeal pain—Timolol—glaucoma	0.00484	0.0129	CcSEcCtD
Amlexanox—Paraesthesia—Diclofenamide—glaucoma	0.0045	0.012	CcSEcCtD
Amlexanox—Nervous system disorder—Latanoprost—glaucoma	0.00438	0.0117	CcSEcCtD
Amlexanox—S100A13—Tizanidine—Clonidine—glaucoma	0.00435	0.191	CbGdCrCtD
Amlexanox—Gastrointestinal disorder—Diclofenamide—glaucoma	0.00433	0.0116	CcSEcCtD
Amlexanox—Paraesthesia—Levobunolol—glaucoma	0.00432	0.0116	CcSEcCtD
Amlexanox—Stomatitis—Pilocarpine—glaucoma	0.00423	0.0113	CcSEcCtD
Amlexanox—Pain—Carbachol—glaucoma	0.00418	0.0112	CcSEcCtD
Amlexanox—Liver function test abnormal—Clonidine—glaucoma	0.00415	0.0111	CcSEcCtD
Amlexanox—Paraesthesia—Methazolamide—glaucoma	0.00414	0.0111	CcSEcCtD
Amlexanox—Pain—Levobunolol—glaucoma	0.00412	0.011	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Methazolamide—glaucoma	0.00398	0.0107	CcSEcCtD
Amlexanox—Pain—Latanoprost—glaucoma	0.00382	0.0102	CcSEcCtD
Amlexanox—Nervous system disorder—Apraclonidine—glaucoma	0.0035	0.00936	CcSEcCtD
Amlexanox—Headache—Metipranolol—glaucoma	0.00345	0.00922	CcSEcCtD
Amlexanox—Nervous system disorder—Bimatoprost—glaucoma	0.00339	0.00908	CcSEcCtD
Amlexanox—Nausea—Metipranolol—glaucoma	0.00327	0.00874	CcSEcCtD
Amlexanox—Paraesthesia—Apraclonidine—glaucoma	0.00321	0.00857	CcSEcCtD
Amlexanox—Headache—Carteolol—glaucoma	0.00319	0.00854	CcSEcCtD
Amlexanox—Headache—Diclofenamide—glaucoma	0.00314	0.00839	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Apraclonidine—glaucoma	0.00308	0.00824	CcSEcCtD
Amlexanox—Headache—Carbachol—glaucoma	0.00306	0.00819	CcSEcCtD
Amlexanox—Pain—Apraclonidine—glaucoma	0.00305	0.00816	CcSEcCtD
Amlexanox—Nausea—Carteolol—glaucoma	0.00303	0.0081	CcSEcCtD
Amlexanox—Headache—Levobunolol—glaucoma	0.00302	0.00807	CcSEcCtD
Amlexanox—Nervous system disorder—Brimonidine—glaucoma	0.00301	0.00804	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Bimatoprost—glaucoma	0.00299	0.00799	CcSEcCtD
Amlexanox—Nausea—Diclofenamide—glaucoma	0.00298	0.00796	CcSEcCtD
Amlexanox—Pain—Bimatoprost—glaucoma	0.00296	0.00792	CcSEcCtD
Amlexanox—Liver function test abnormal—Timolol—glaucoma	0.00295	0.00789	CcSEcCtD
Amlexanox—Stomatitis—Betaxolol—glaucoma	0.00294	0.00786	CcSEcCtD
Amlexanox—Nausea—Carbachol—glaucoma	0.00291	0.00777	CcSEcCtD
Amlexanox—Headache—Methazolamide—glaucoma	0.00289	0.00773	CcSEcCtD
Amlexanox—Paraesthesia—Acetazolamide—glaucoma	0.00287	0.00767	CcSEcCtD
Amlexanox—Nausea—Levobunolol—glaucoma	0.00286	0.00765	CcSEcCtD
Amlexanox—Nervous system disorder—Travoprost—glaucoma	0.00286	0.00764	CcSEcCtD
Amlexanox—Nervous system disorder—Brinzolamide—glaucoma	0.00282	0.00755	CcSEcCtD
Amlexanox—Headache—Latanoprost—glaucoma	0.0028	0.00748	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Acetazolamide—glaucoma	0.00276	0.00737	CcSEcCtD
Amlexanox—Paraesthesia—Brimonidine—glaucoma	0.00275	0.00736	CcSEcCtD
Amlexanox—Nausea—Methazolamide—glaucoma	0.00274	0.00733	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Brimonidine—glaucoma	0.00265	0.00708	CcSEcCtD
Amlexanox—Paraesthesia—Dorzolamide—glaucoma	0.00263	0.00703	CcSEcCtD
Amlexanox—Pain—Brimonidine—glaucoma	0.00262	0.00701	CcSEcCtD
Amlexanox—Paraesthesia—Brinzolamide—glaucoma	0.00258	0.00691	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Travoprost—glaucoma	0.00252	0.00673	CcSEcCtD
Amlexanox—Pain—Dorzolamide—glaucoma	0.0025	0.00669	CcSEcCtD
Amlexanox—Pain—Travoprost—glaucoma	0.00249	0.00667	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Brinzolamide—glaucoma	0.00248	0.00664	CcSEcCtD
Amlexanox—Paraesthesia—Pilocarpine—glaucoma	0.00248	0.00664	CcSEcCtD
Amlexanox—Pain—Brinzolamide—glaucoma	0.00246	0.00658	CcSEcCtD
Amlexanox—S100A13—Hydrochlorothiazide—Diclofenamide—glaucoma	0.00244	0.107	CbGdCrCtD
Amlexanox—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00239	0.00639	CcSEcCtD
Amlexanox—Pain—Pilocarpine—glaucoma	0.00237	0.00633	CcSEcCtD
Amlexanox—Headache—Apraclonidine—glaucoma	0.00224	0.00598	CcSEcCtD
Amlexanox—Headache—Bimatoprost—glaucoma	0.00217	0.0058	CcSEcCtD
Amlexanox—Nervous system disorder—Clonidine—glaucoma	0.00217	0.00579	CcSEcCtD
Amlexanox—Nausea—Apraclonidine—glaucoma	0.00212	0.00567	CcSEcCtD
Amlexanox—Nausea—Bimatoprost—glaucoma	0.00206	0.0055	CcSEcCtD
Amlexanox—Headache—Acetazolamide—glaucoma	0.002	0.00535	CcSEcCtD
Amlexanox—Paraesthesia—Clonidine—glaucoma	0.00198	0.0053	CcSEcCtD
Amlexanox—Headache—Brimonidine—glaucoma	0.00192	0.00514	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Clonidine—glaucoma	0.00191	0.0051	CcSEcCtD
Amlexanox—Nausea—Acetazolamide—glaucoma	0.0019	0.00507	CcSEcCtD
Amlexanox—Pain—Clonidine—glaucoma	0.00189	0.00505	CcSEcCtD
Amlexanox—Nervous system disorder—Betaxolol—glaucoma	0.00189	0.00504	CcSEcCtD
Amlexanox—Headache—Dorzolamide—glaucoma	0.00183	0.0049	CcSEcCtD
Amlexanox—Headache—Travoprost—glaucoma	0.00183	0.00488	CcSEcCtD
Amlexanox—Nausea—Brimonidine—glaucoma	0.00182	0.00487	CcSEcCtD
Amlexanox—Headache—Brinzolamide—glaucoma	0.0018	0.00482	CcSEcCtD
Amlexanox—Nausea—Dorzolamide—glaucoma	0.00174	0.00465	CcSEcCtD
Amlexanox—Headache—Pilocarpine—glaucoma	0.00173	0.00463	CcSEcCtD
Amlexanox—Nausea—Travoprost—glaucoma	0.00173	0.00463	CcSEcCtD
Amlexanox—Paraesthesia—Betaxolol—glaucoma	0.00173	0.00462	CcSEcCtD
Amlexanox—Nausea—Brinzolamide—glaucoma	0.00171	0.00457	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Betaxolol—glaucoma	0.00166	0.00444	CcSEcCtD
Amlexanox—Pain—Betaxolol—glaucoma	0.00164	0.0044	CcSEcCtD
Amlexanox—Nausea—Pilocarpine—glaucoma	0.00164	0.00439	CcSEcCtD
Amlexanox—S100A13—Alprenolol—Metipranolol—glaucoma	0.0016	0.07	CbGdCrCtD
Amlexanox—Nervous system disorder—Timolol—glaucoma	0.00154	0.00412	CcSEcCtD
Amlexanox—Paraesthesia—Timolol—glaucoma	0.00141	0.00377	CcSEcCtD
Amlexanox—Headache—Clonidine—glaucoma	0.00138	0.0037	CcSEcCtD
Amlexanox—Gastrointestinal disorder—Timolol—glaucoma	0.00136	0.00363	CcSEcCtD
Amlexanox—Pain—Timolol—glaucoma	0.00134	0.00359	CcSEcCtD
Amlexanox—Nausea—Clonidine—glaucoma	0.00131	0.00351	CcSEcCtD
Amlexanox—Headache—Betaxolol—glaucoma	0.0012	0.00322	CcSEcCtD
Amlexanox—Nausea—Betaxolol—glaucoma	0.00114	0.00305	CcSEcCtD
Amlexanox—S100A13—Alprenolol—Betaxolol—glaucoma	0.00112	0.049	CbGdCrCtD
Amlexanox—Headache—Timolol—glaucoma	0.000984	0.00263	CcSEcCtD
Amlexanox—Nausea—Timolol—glaucoma	0.000933	0.0025	CcSEcCtD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—BAD—glaucoma	0.000513	0.00155	CbGpPWpGaD
Amlexanox—S100A12—Immune System—TXN—glaucoma	0.000512	0.00155	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—MMP1—glaucoma	0.000511	0.00155	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—TXN—glaucoma	0.000502	0.00152	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000499	0.00151	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—NTRK1—glaucoma	0.000497	0.0015	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—CAV1—glaucoma	0.00049	0.00148	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—BAD—glaucoma	0.000489	0.00148	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—BAD—glaucoma	0.000489	0.00148	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—BAD—glaucoma	0.000489	0.00148	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—LRP12—glaucoma	0.000488	0.00148	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—RPTOR—glaucoma	0.000485	0.00147	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—BAD—glaucoma	0.000485	0.00147	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—BAD—glaucoma	0.000481	0.00145	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—BAD—glaucoma	0.000479	0.00145	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NCK2—glaucoma	0.00047	0.00142	CbGpPWpGaD
Amlexanox—PDE4B—Myometrial Relaxation and Contraction Pathways—NOS3—glaucoma	0.000469	0.00142	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—FN1—glaucoma	0.000467	0.00141	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.00046	0.00139	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—LRP12—glaucoma	0.000455	0.00138	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—BAD—glaucoma	0.000453	0.00137	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—OPN4—glaucoma	0.000441	0.00134	CbGpPWpGaD
Amlexanox—IL3—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.00044	0.00133	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CTSA—glaucoma	0.00044	0.00133	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—BAD—glaucoma	0.000433	0.00131	CbGpPWpGaD
Amlexanox—FGF1—Disease—FGFR1OP—glaucoma	0.000419	0.00127	CbGpPWpGaD
Amlexanox—FGF1—Disease—HEYL—glaucoma	0.000419	0.00127	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HEYL—glaucoma	0.00041	0.00124	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—CDKN1B—glaucoma	0.000409	0.00124	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—NGF—glaucoma	0.000404	0.00122	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—HDAC9—glaucoma	0.0004	0.00121	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—PTGFR—glaucoma	0.000397	0.0012	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling of activated FGFR—CDKN1B—glaucoma	0.000391	0.00118	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB4—CDKN1B—glaucoma	0.000385	0.00116	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—EDN1—glaucoma	0.000384	0.00116	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—OPN4—glaucoma	0.000384	0.00116	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—C3—glaucoma	0.000383	0.00116	CbGpPWpGaD
Amlexanox—FGF1—Signaling by SCF-KIT—MMP9—glaucoma	0.000379	0.00115	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—NOS3—glaucoma	0.000371	0.00112	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TXNIP—glaucoma	0.00037	0.00112	CbGpPWpGaD
Amlexanox—FGF1—Downstream signal transduction—CDKN1B—glaucoma	0.000368	0.00111	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—BCL2L1—glaucoma	0.000367	0.00111	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—OPN4—glaucoma	0.000366	0.00111	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR—CDKN1B—glaucoma	0.000366	0.00111	CbGpPWpGaD
Amlexanox—FGF1—Signaling by ERBB2—CDKN1B—glaucoma	0.000364	0.0011	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TBK1—glaucoma	0.000363	0.0011	CbGpPWpGaD
Amlexanox—FGF1—DAP12 signaling—CDKN1B—glaucoma	0.000362	0.0011	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HEYL—glaucoma	0.000357	0.00108	CbGpPWpGaD
Amlexanox—FGF1—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—glaucoma	0.000357	0.00108	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—EDN1—glaucoma	0.000349	0.00106	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—PTGFR—glaucoma	0.000346	0.00105	CbGpPWpGaD
Amlexanox—FGF1—DAP12 interactions—CDKN1B—glaucoma	0.000341	0.00103	CbGpPWpGaD
Amlexanox—FGF1—Fc epsilon receptor (FCERI) signaling—CDKN1B—glaucoma	0.000341	0.00103	CbGpPWpGaD
Amlexanox—FGF1—Signaling by FGFR in disease—CDKN1B—glaucoma	0.000341	0.00103	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HEYL—glaucoma	0.00034	0.00103	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—SMO—glaucoma	0.000339	0.00103	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000339	0.00102	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—OPN4—glaucoma	0.000338	0.00102	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR—CDKN1B—glaucoma	0.000338	0.00102	CbGpPWpGaD
Amlexanox—IL3—GPCR downstream signaling—C3—glaucoma	0.000336	0.00102	CbGpPWpGaD
Amlexanox—FGF1—Signaling by EGFR in Cancer—CDKN1B—glaucoma	0.000335	0.00101	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—BAD—glaucoma	0.000333	0.00101	CbGpPWpGaD
Amlexanox—FGF1—Signaling by PDGF—CDKN1B—glaucoma	0.000333	0.00101	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—BAD—glaucoma	0.000333	0.00101	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—PTGFR—glaucoma	0.000329	0.000996	CbGpPWpGaD
Amlexanox—FGF1—Immune System—C1QB—glaucoma	0.000328	0.000993	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000321	0.00097	CbGpPWpGaD
Amlexanox—IL3—Immune System—IL1A—glaucoma	0.000317	0.00096	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—OPN4—glaucoma	0.000316	0.000955	CbGpPWpGaD
Amlexanox—FGF1—B Cell Activation—CDKN1B—glaucoma	0.000315	0.000954	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HEYL—glaucoma	0.000315	0.000952	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—SMO—glaucoma	0.000313	0.000946	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—RPTOR—glaucoma	0.000311	0.000941	CbGpPWpGaD
Amlexanox—IL3—Signaling by GPCR—C3—glaucoma	0.000305	0.000923	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—PTGFR—glaucoma	0.000305	0.000922	CbGpPWpGaD
Amlexanox—FGF1—NGF signalling via TRKA from the plasma membrane—CDKN1B—glaucoma	0.000302	0.000913	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NCK2—glaucoma	0.000301	0.000911	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—SMO—glaucoma	0.000295	0.000894	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HEYL—glaucoma	0.000293	0.000888	CbGpPWpGaD
Amlexanox—FGF1—Immune System—TXN—glaucoma	0.000292	0.000885	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NTRK2—glaucoma	0.000286	0.000866	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—PTGFR—glaucoma	0.000284	0.00086	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—SMO—glaucoma	0.000281	0.000851	CbGpPWpGaD
Amlexanox—IL3—Immune System—C3—glaucoma	0.000279	0.000843	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—RPTOR—glaucoma	0.000271	0.000819	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—VEGFA—glaucoma	0.000267	0.000808	CbGpPWpGaD
Amlexanox—IL3—Immune System—BCL2L1—glaucoma	0.000267	0.000807	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000267	0.000807	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NCK2—glaucoma	0.000262	0.000793	CbGpPWpGaD
Amlexanox—FGF1—Disease—HDAC9—glaucoma	0.000261	0.000791	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—SMO—glaucoma	0.00026	0.000787	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—RPTOR—glaucoma	0.000258	0.00078	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—HDAC9—glaucoma	0.000256	0.000775	CbGpPWpGaD
Amlexanox—S100A12—Immune System—IL1A—glaucoma	0.000254	0.000769	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NCK2—glaucoma	0.00025	0.000755	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—EDN1—glaucoma	0.000246	0.000745	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NGFR—glaucoma	0.000245	0.000743	CbGpPWpGaD
Amlexanox—IL3—Immune System—BAD—glaucoma	0.000242	0.000731	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—RPTOR—glaucoma	0.000238	0.000722	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NTRK1—glaucoma	0.000233	0.000706	CbGpPWpGaD
Amlexanox—FGF1—Signaling by NGF—CDKN1B—glaucoma	0.000232	0.000702	CbGpPWpGaD
Amlexanox—S100A12—Innate Immune System—CDKN1B—glaucoma	0.000232	0.000701	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NCK2—glaucoma	0.000231	0.000699	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000229	0.000691	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—EDN1—glaucoma	0.000224	0.000677	CbGpPWpGaD
Amlexanox—S100A12—Immune System—C3—glaucoma	0.000223	0.000676	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—HDAC9—glaucoma	0.000223	0.000675	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—RPTOR—glaucoma	0.000222	0.000673	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—C3—glaucoma	0.000219	0.000663	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NCK2—glaucoma	0.000215	0.000652	CbGpPWpGaD
Amlexanox—PDE4C—GPCR downstream signaling—C3—glaucoma	0.000215	0.000651	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CDKN2B—glaucoma	0.000215	0.00065	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—EDN1—glaucoma	0.000214	0.000649	CbGpPWpGaD
Amlexanox—S100A12—Immune System—BCL2L1—glaucoma	0.000214	0.000647	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—HDAC9—glaucoma	0.000212	0.000642	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—C3—glaucoma	0.00021	0.000637	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—BCL2L1—glaucoma	0.00021	0.000635	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—EDN1—glaucoma	0.000206	0.000624	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—EDN1—glaucoma	0.000204	0.000618	CbGpPWpGaD
Amlexanox—IL3—Hemostasis—TP53—glaucoma	0.000202	0.00061	CbGpPWpGaD
Amlexanox—FGF1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000201	0.00061	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—SMO—glaucoma	0.0002	0.000606	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—HDAC9—glaucoma	0.000196	0.000594	CbGpPWpGaD
Amlexanox—PDE4C—Signaling by GPCR—C3—glaucoma	0.000195	0.000591	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—EDN1—glaucoma	0.000195	0.000589	CbGpPWpGaD
Amlexanox—S100A12—Immune System—BAD—glaucoma	0.000194	0.000586	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—BAD—glaucoma	0.00019	0.000575	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NGF—glaucoma	0.00019	0.000573	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—EDN1—glaucoma	0.000189	0.000571	CbGpPWpGaD
Amlexanox—PDE4D—GPCR downstream signaling—C3—glaucoma	0.000187	0.000567	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—EDN1—glaucoma	0.000185	0.000561	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NTRK2—glaucoma	0.000183	0.000555	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—HDAC9—glaucoma	0.000183	0.000554	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—BAD—glaucoma	0.000183	0.000552	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—C3—glaucoma	0.00018	0.000545	CbGpPWpGaD
Amlexanox—PDE4A—GPCR downstream signaling—C3—glaucoma	0.000178	0.000539	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—SMO—glaucoma	0.000174	0.000528	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—EDN1—glaucoma	0.000172	0.000519	CbGpPWpGaD
Amlexanox—PDE4D—Signaling by GPCR—C3—glaucoma	0.00017	0.000515	CbGpPWpGaD
Amlexanox—IL3—Immune System—CDKN1B—glaucoma	0.000168	0.000509	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—APOE—glaucoma	0.000168	0.000508	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CAV1—glaucoma	0.000166	0.000503	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—SMO—glaucoma	0.000166	0.000502	CbGpPWpGaD
Amlexanox—PDE4B—GPCR downstream signaling—C3—glaucoma	0.000165	0.000499	CbGpPWpGaD
Amlexanox—PDE4A—Signaling by GPCR—C3—glaucoma	0.000162	0.00049	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NTRK2—glaucoma	0.00016	0.000483	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—FN1—glaucoma	0.000158	0.000479	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NGFR—glaucoma	0.000157	0.000476	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—BAD—glaucoma	0.000156	0.000473	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—SMO—glaucoma	0.000154	0.000465	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NTRK2—glaucoma	0.000152	0.00046	CbGpPWpGaD
Amlexanox—PDE4B—Signaling by GPCR—C3—glaucoma	0.00015	0.000453	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NTRK1—glaucoma	0.000149	0.000452	CbGpPWpGaD
Amlexanox—FGF1—Immune System—IL1A—glaucoma	0.000145	0.000439	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—SMO—glaucoma	0.000143	0.000434	CbGpPWpGaD
Amlexanox—FGF1—Disease—CDKN2B—glaucoma	0.000141	0.000425	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NTRK2—glaucoma	0.000141	0.000425	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CDKN2B—glaucoma	0.000138	0.000417	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NGFR—glaucoma	0.000137	0.000414	CbGpPWpGaD
Amlexanox—S100A12—Immune System—CDKN1B—glaucoma	0.000135	0.000408	CbGpPWpGaD
Amlexanox—FGF1—Innate Immune System—CDKN1B—glaucoma	0.000132	0.000401	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—EDN1—glaucoma	0.000132	0.0004	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NTRK2—glaucoma	0.000131	0.000396	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NGFR—glaucoma	0.00013	0.000394	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NTRK1—glaucoma	0.00013	0.000394	CbGpPWpGaD
Amlexanox—FGF1—Immune System—C3—glaucoma	0.000128	0.000386	CbGpPWpGaD
Amlexanox—FGF1—Adaptive Immune System—CDKN1B—glaucoma	0.000127	0.000385	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—NOS3—glaucoma	0.000126	0.00038	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NTRK1—glaucoma	0.000124	0.000375	CbGpPWpGaD
Amlexanox—FGF1—Immune System—BCL2L1—glaucoma	0.000122	0.00037	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NGF—glaucoma	0.000121	0.000367	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NGFR—glaucoma	0.000121	0.000365	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CDKN2B—glaucoma	0.00012	0.000363	CbGpPWpGaD
Amlexanox—FGF1—Disease—MTHFR—glaucoma	0.000118	0.000357	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—C3—glaucoma	0.000115	0.000349	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—EDN1—glaucoma	0.000115	0.000348	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NTRK1—glaucoma	0.000115	0.000347	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CDKN2B—glaucoma	0.000114	0.000345	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NGFR—glaucoma	0.000112	0.00034	CbGpPWpGaD
Amlexanox—FGF1—Immune System—BAD—glaucoma	0.000111	0.000335	CbGpPWpGaD
Amlexanox—FGF1—Disease—APOE—glaucoma	0.00011	0.000332	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—EDN1—glaucoma	0.000109	0.000331	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—CDKN1B—glaucoma	0.000109	0.000329	CbGpPWpGaD
Amlexanox—FGF1—Disease—CAV1—glaucoma	0.000109	0.000329	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—APOE—glaucoma	0.000107	0.000325	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NTRK1—glaucoma	0.000107	0.000323	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CAV1—glaucoma	0.000106	0.000322	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NGF—glaucoma	0.000106	0.00032	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CDKN2B—glaucoma	0.000106	0.000319	CbGpPWpGaD
Amlexanox—FGF1—Disease—BAD—glaucoma	0.000102	0.000309	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—FN1—glaucoma	0.000101	0.000307	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—EDN1—glaucoma	0.000101	0.000307	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—MMP9—glaucoma	0.000101	0.000305	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NGF—glaucoma	0.000101	0.000304	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—C3—glaucoma	0.0001	0.000304	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—BAD—glaucoma	0.0001	0.000303	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CDKN2B—glaucoma	9.85e-05	0.000298	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—C3—glaucoma	9.57e-05	0.000289	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—EDN1—glaucoma	9.45e-05	0.000286	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—APOE—glaucoma	9.36e-05	0.000283	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NGF—glaucoma	9.31e-05	0.000282	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CAV1—glaucoma	9.27e-05	0.00028	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—VEGFA—glaucoma	9.05e-05	0.000274	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—APOE—glaucoma	8.91e-05	0.000269	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—C3—glaucoma	8.85e-05	0.000268	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CAV1—glaucoma	8.82e-05	0.000267	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—FN1—glaucoma	8.82e-05	0.000267	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—BAD—glaucoma	8.72e-05	0.000264	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NGF—glaucoma	8.68e-05	0.000263	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—FN1—glaucoma	8.4e-05	0.000254	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—BAD—glaucoma	8.3e-05	0.000251	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—C3—glaucoma	8.25e-05	0.00025	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—APOE—glaucoma	8.24e-05	0.000249	CbGpPWpGaD
Amlexanox—FGF1—Disease—NOS3—glaucoma	8.22e-05	0.000249	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CAV1—glaucoma	8.16e-05	0.000247	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—NOS3—glaucoma	8.05e-05	0.000244	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—FN1—glaucoma	7.77e-05	0.000235	CbGpPWpGaD
Amlexanox—FGF1—Immune System—CDKN1B—glaucoma	7.71e-05	0.000233	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—APOE—glaucoma	7.68e-05	0.000232	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—BAD—glaucoma	7.68e-05	0.000232	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CAV1—glaucoma	7.61e-05	0.00023	CbGpPWpGaD
Amlexanox—FGF1—Disease—PTGS2—glaucoma	7.52e-05	0.000227	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—FN1—glaucoma	7.25e-05	0.000219	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—BAD—glaucoma	7.16e-05	0.000217	CbGpPWpGaD
Amlexanox—FGF1—Disease—CDKN1B—glaucoma	7.12e-05	0.000215	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—NOS3—glaucoma	7.01e-05	0.000212	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—CDKN1B—glaucoma	6.97e-05	0.000211	CbGpPWpGaD
Amlexanox—IL3—Signaling Pathways—TP53—glaucoma	6.84e-05	0.000207	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—NOS3—glaucoma	6.67e-05	0.000202	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—MMP9—glaucoma	6.46e-05	0.000195	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—NOS3—glaucoma	6.17e-05	0.000187	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—CDKN1B—glaucoma	6.07e-05	0.000184	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—VEGFA—glaucoma	5.8e-05	0.000175	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—CDKN1B—glaucoma	5.78e-05	0.000175	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—NOS3—glaucoma	5.76e-05	0.000174	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—MMP9—glaucoma	5.62e-05	0.00017	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—MMP9—glaucoma	5.35e-05	0.000162	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—CDKN1B—glaucoma	5.35e-05	0.000162	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—VEGFA—glaucoma	5.05e-05	0.000153	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—CDKN1B—glaucoma	4.99e-05	0.000151	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—MMP9—glaucoma	4.95e-05	0.00015	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—VEGFA—glaucoma	4.81e-05	0.000145	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—MMP9—glaucoma	4.62e-05	0.00014	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—VEGFA—glaucoma	4.45e-05	0.000135	CbGpPWpGaD
Amlexanox—PDE4C—Signaling Pathways—TP53—glaucoma	4.38e-05	0.000133	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—VEGFA—glaucoma	4.15e-05	0.000125	CbGpPWpGaD
Amlexanox—PDE4D—Signaling Pathways—TP53—glaucoma	3.82e-05	0.000115	CbGpPWpGaD
Amlexanox—PDE4A—Signaling Pathways—TP53—glaucoma	3.63e-05	0.00011	CbGpPWpGaD
Amlexanox—PDE4B—Signaling Pathways—TP53—glaucoma	3.36e-05	0.000102	CbGpPWpGaD
Amlexanox—FGF1—Signaling Pathways—TP53—glaucoma	3.13e-05	9.48e-05	CbGpPWpGaD
